Trump orders MMR vaccine as LSD-targeted drug passes Phase 3 trial
read at Endpoints ↗Positive readoutNeutral
The latest Endpoints Weekly notes that President Trump placed an order for the measles‑mumps‑rubella (MMR) vaccine.
The newsletter also reports that a drug being developed for LSD‑related indications successfully completed a Phase 3 clinical trial, indicating it met its primary endpoints.
The edition mentions additional stories but does not provide further details in the excerpt.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Trump’s MMR order; LSD drug clears Phase 3 test; and more”
read at Endpoints ↗86 words · retrieved 32m ago
comments(0)
5-min edit window · permanent after that